norethindrone has been researched along with telaprevir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Adda, N; Garg, V; Kauffman, R; Smith, F; van Heeswijk, R; Yang, Y | 1 |
1 trial(s) available for norethindrone and telaprevir
| Article | Year |
|---|---|
The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir.
Topics: Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hepacivirus; Humans; Luteinizing Hormone; Middle Aged; Norethindrone; Oligopeptides; Progesterone; Protease Inhibitors; Young Adult | 2012 |
1 other study(ies) available for norethindrone and telaprevir
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |